THE ROLE AND MECHANISM OF UPREGULATED TYPE I INTERFERON SIGNALING PATHWAY IN THE PATHOGENESIS OF CHRONIC MYELOMONOCYTIC LEUKEMIA

IF 0.7 Q4 HEMATOLOGY Leukemia Research Reports Pub Date : 2024-01-01 DOI:10.1016/j.lrr.2024.100429
L. Na, S. Yuqian
{"title":"THE ROLE AND MECHANISM OF UPREGULATED TYPE I INTERFERON SIGNALING PATHWAY IN THE PATHOGENESIS OF CHRONIC MYELOMONOCYTIC LEUKEMIA","authors":"L. Na,&nbsp;S. Yuqian","doi":"10.1016/j.lrr.2024.100429","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Chronic Myelomonocytic Leukemia (CMML) is a rare, malignant hematopoietic system tumour whose pathogenesis remains unclear. This primarily affects elderly males and may transform into acute myeloid leukemia. Elevated innate immune and inflammation-related pathways were found in CMML patients' monocytes. Activation of type I interferon signalling pathway was significant and correlated with prognosis. Strong expression of interferon-regulated genes in patients pointed to type 1 interferon signalling's role in CMML's pathogenesis. TET2 and SRSF2 mutations, affecting gene expression and cellular function, are common in CMML, with a synergistic effect shown in mouse model experiments.</p></div><div><h3>Methods</h3><p>We studied 14 untreated CMML patients, analysing their peripheral blood monocytes and 13 inflammatory cytokines via transcriptome sequencing and Cytometric Bead Array. SRSF2-P95H/TET2 mutation cell lines were also created.</p></div><div><h3>Results</h3><p>Exome and transcriptome sequencing in 14 CMML patients revealed frequent TET2, ASXL1, and SRSF2 mutations. Compared to controls, CMML cells displayed activated innate immune and inflammation pathways, including elevated levels of IL-10, IFN-α2, IL-8, IL-12p70, IL-6, and IL-17A. Higher 1-IFN scores, indicating the activation level of the type 1 interferon pathway, were seen in MP-CMML patients, suggesting a link with poor prognosis. In vitro, interferon pathway inhibition induced apoptosis in CMML monocytes and reduced protein P38 phosphorylation, inhibiting cell proliferation in THP-1/U937. TET2 loss-of-function mutations and SRSF2-P95H mutations overexpressed type 1 interferon pathway genes, leading to increased culture supernatant interferon levels in HEK-293T cells.</p></div><div><h3>Conclusions</h3><p>Study shows TET2 loss-of-function/SRSF2-P95H mutations in CMML trigger type I interferon pathway activation, promoting P38 and PI3K phosphorylation, potentially partly causing CMML.</p></div>","PeriodicalId":38435,"journal":{"name":"Leukemia Research Reports","volume":"21 ","pages":"Article 100429"},"PeriodicalIF":0.7000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213048924000190/pdfft?md5=07280409c9a88f59574c7669641476da&pid=1-s2.0-S2213048924000190-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Leukemia Research Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213048924000190","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Chronic Myelomonocytic Leukemia (CMML) is a rare, malignant hematopoietic system tumour whose pathogenesis remains unclear. This primarily affects elderly males and may transform into acute myeloid leukemia. Elevated innate immune and inflammation-related pathways were found in CMML patients' monocytes. Activation of type I interferon signalling pathway was significant and correlated with prognosis. Strong expression of interferon-regulated genes in patients pointed to type 1 interferon signalling's role in CMML's pathogenesis. TET2 and SRSF2 mutations, affecting gene expression and cellular function, are common in CMML, with a synergistic effect shown in mouse model experiments.

Methods

We studied 14 untreated CMML patients, analysing their peripheral blood monocytes and 13 inflammatory cytokines via transcriptome sequencing and Cytometric Bead Array. SRSF2-P95H/TET2 mutation cell lines were also created.

Results

Exome and transcriptome sequencing in 14 CMML patients revealed frequent TET2, ASXL1, and SRSF2 mutations. Compared to controls, CMML cells displayed activated innate immune and inflammation pathways, including elevated levels of IL-10, IFN-α2, IL-8, IL-12p70, IL-6, and IL-17A. Higher 1-IFN scores, indicating the activation level of the type 1 interferon pathway, were seen in MP-CMML patients, suggesting a link with poor prognosis. In vitro, interferon pathway inhibition induced apoptosis in CMML monocytes and reduced protein P38 phosphorylation, inhibiting cell proliferation in THP-1/U937. TET2 loss-of-function mutations and SRSF2-P95H mutations overexpressed type 1 interferon pathway genes, leading to increased culture supernatant interferon levels in HEK-293T cells.

Conclusions

Study shows TET2 loss-of-function/SRSF2-P95H mutations in CMML trigger type I interferon pathway activation, promoting P38 and PI3K phosphorylation, potentially partly causing CMML.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
I 型干扰素信号通路上调在慢性粒细胞白血病发病机制中的作用和机制
导言 慢性粒细胞白血病(CMML)是一种罕见的恶性造血系统肿瘤,其发病机制尚不清楚。它主要影响老年男性,并可能转化为急性髓性白血病。在 CMML 患者的单核细胞中发现了先天免疫和炎症相关途径的升高。I 型干扰素信号通路的激活非常显著,并与预后相关。患者体内干扰素调控基因的强表达表明,1型干扰素信号在CMML的发病机制中发挥作用。TET2和SRSF2突变影响基因表达和细胞功能,在CMML中很常见,在小鼠模型实验中显示出协同效应。方法我们研究了14名未经治疗的CMML患者,通过转录组测序和细胞计数珠阵列分析了他们的外周血单核细胞和13种炎症细胞因子。结果14名CMML患者的基因组和转录组测序显示,TET2、ASXL1和SRSF2突变频繁。与对照组相比,CMML 细胞显示出激活的先天免疫和炎症通路,包括 IL-10、IFN-α2、IL-8、IL-12p70、IL-6 和 IL-17A 水平升高。MP-CMML患者的1-IFN评分较高,表明1型干扰素通路的活化水平较高,这与预后不良有关。在体外,干扰素通路抑制可诱导 CMML 单核细胞凋亡,降低蛋白 P38 磷酸化,抑制 THP-1/U937 细胞增殖。TET2功能缺失突变和SRSF2-P95H突变过度表达1型干扰素通路基因,导致HEK-293T细胞培养上清干扰素水平升高。结论研究表明,CMML中的TET2功能缺失/SRSF2-P95H突变可触发I型干扰素通路激活,促进P38和PI3K磷酸化,可能部分导致CMML。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Leukemia Research Reports
Leukemia Research Reports Medicine-Oncology
CiteScore
1.70
自引率
0.00%
发文量
70
审稿时长
23 weeks
期刊最新文献
Management of hemolytic transfusion reactions in a patient with chronic myelomonocytic leukemia and rare antibodies: A case report Acute lower limb ischemia revealing hypo granular acute promyelocytic leukemia Treatment of Vietnamese patients diagnosed with myelodysplastic neoplasms: Practical experience in a developing country Late-onset Familial Hemophagocytic Lymphohistiocytosis in a survivor of Hodgkin's Lymphoma Posterior reversible encephalopathy syndrome (PRES) and myeloma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1